Group 1 - Lucid confirmed a 1-for-10 reverse stock split effective August 29, 2025, to improve its share price and maintain Nasdaq compliance [1] - The reverse split will reduce outstanding shares from approximately 3.07 billion to 307.3 million and authorized shares from 15 billion to 1.5 billion [1] - Trading on a split-adjusted basis will commence on September 2, 2025, under the existing ticker symbol [1] Group 2 - AI price prediction models project Lucid's average share price to be $2.05 by August 29, which translates to an adjusted price of around $20.50 post-split [3][4] - The current stock price is $2.06, indicating a slight decrease of 0.24% in the predicted price [4] - All three AI models show a rare alignment in their predictions, reflecting a lack of bullish catalysts for the stock [8] Group 3 - Lucid's market cap has decreased by over 30% in the past six months, now standing at $6.44 billion [8] - The company faces high execution risk due to weak deliveries, significant cash burn, and intense competition in the EV market [9] - While the reverse stock split may provide temporary relief above the $20 level, analysts warn that the stock could decline again without new catalysts [10]

Core Viewpoint - Lucid Group Inc announced a 1-for-10 reverse stock split and a reduction in authorized shares, reflecting ongoing challenges in performance and production guidance [1][2][3]. Group 1: Stock Split and Share Reduction - The reverse stock split will reduce the number of authorized shares from 15 billion to 1.5 billion, effective after market close on August 29, with trading on a split-adjusted basis starting September 2 [2]. - The stock split is occurring as Lucid shares have declined approximately 30% since the beginning of the year [3]. Group 2: Production and Financial Performance - In the second quarter, Lucid produced 3,863 vehicles and delivered 3,309 vehicles, missing analyst estimates on both revenue and earnings [3][4]. - The company has revised its production guidance for 2025, lowering it from approximately 20,000 vehicles to a range of 18,000 to 20,000 vehicles, with expectations for Lucid Gravity production to ramp up in the second half of the year [4]. Group 3: Market Reaction - Following the announcement, Lucid shares were up 0.93% in after-hours trading, priced at $2.11 at the time of publication [7].

Core Viewpoint - SU Group Holdings Limited will implement a 1-for-10 reverse stock split, increase its authorized share capital, and alter its share capital structure, effective August 25, 2025, to comply with Nasdaq listing requirements [1][3]. Share Consolidation - The reverse stock split will consolidate every ten ordinary shares into one, changing the par value from HK$0.01 to HK$0.10 [2][4]. - The number of issued and outstanding ordinary shares will decrease from approximately 13,847,500 to about 1,384,750 [4]. - The new CUSIP number assigned due to the consolidation is G8552M117 [2]. Share Capital Increase - The authorized share capital will increase from HK$7,500,000 (75,000,000 shares) to HK$75,000,000 (750,000,000 shares) [6]. Share Capital Alteration - The share capital alteration will re-designate the authorized share capital into 749,098,320 Class A ordinary shares and 901,680 Class B ordinary shares [7]. - The voting power of Mr. Chan Ming Dave, the Company's chairman, will increase from approximately 65.84% to 98.96% due to the new share structure [8]. Additional Information - Outstanding stock options and other convertible securities will be adjusted based on the 1-for-10 ratio [9]. - The trading of Class A Ordinary Shares on Nasdaq is expected to continue without disruption [9]. - SU Group provides integrated security-related engineering services, including threat detection and traffic control systems, primarily in Hong Kong [10].

Core Viewpoint - Orion Energy Systems, Inc. has announced a 1-for-10 reverse stock split to comply with Nasdaq's minimum bid price requirement of $1.00 per share, effective August 22, 2025 [1][3]. Group 1: Reverse Stock Split Details - The reverse stock split will reduce the number of shares from approximately 35.2 million to about 3.5 million, and the total authorized shares will decrease from 200 million to 20 million [3]. - Shareholders will not receive fractional shares; instead, they will receive a cash payment based on the closing price prior to the split [3]. - The reverse stock split will also adjust all outstanding options and similar securities proportionally [4]. Group 2: Shareholder Impact - The reverse stock split will affect all shareholders uniformly, maintaining their percentage ownership interest in the company, except for those receiving fractional shares [2]. - Equinity Trust Company, LLC will act as the exchange agent, providing instructions for shareholders with physical stock certificates [5]. Group 3: Company Overview - Orion Energy Systems specializes in energy-efficient solutions, including LED lighting and electric vehicle charging stations, focusing on large national customers and sustainability [6].

Group 1 - Palatin Technologies, Inc. announced a reverse stock split at a ratio of 1-for-50, effective on August 8, 2025, with trading on a split-adjusted basis starting August 11, 2025 [1][2] - The primary goal of the reverse stock split is to increase the per-share market price to comply with NYSE American's Listing Qualifications due to the low selling price of the company's common shares [2] - Stockholders approved the reverse stock split at a ratio of 1-for-50 to 1-for-100 during the annual meeting on July 25, 2025, with the final ratio to be determined by the Board of Directors [3] Group 2 - As of the effective time, every 50 shares of the company's common stock will be combined into one share, with cash provided for any fractional shares [4] - The par value and other terms of the common stock will remain unaffected by the reverse stock split, and the new CUSIP number for the post-split common stock will be 696077 601 [4] - Palatin is a biopharmaceutical company focused on developing first-in-class medicines targeting melanocortin receptor systems for diseases with significant unmet medical needs [5]

Core Viewpoint - Vaxart, Inc. is urging stockholders to vote in favor of a reverse stock split proposal to facilitate relisting on Nasdaq, which is deemed essential for the company's future growth and stockholder value [3][6][11]. Group 1: Importance of Relisting - Relisting on Nasdaq is a strategic imperative for Vaxart, as it enhances visibility, liquidity, and access to a broader range of investors, including institutional ones [4][5]. - A Nasdaq listing is expected to improve market perception and provide credibility, which is crucial for attracting partnerships and funding [5][10]. - The company acknowledges the frustration of stockholders regarding the current share price and emphasizes that a reverse stock split is necessary to meet Nasdaq's listing requirements [3][6]. Group 2: Reverse Stock Split Proposal - The reverse stock split proposal aims to minimize dilution by implementing a narrower split ratio and reducing the authorized share count [7][8]. - The company clarifies that the reverse stock split will not alter the fundamental value of investments, only the number of shares held [7]. - All equity holders, including employees and management, will be equally affected by the reverse stock split, aligning interests in share price appreciation [8]. Group 3: Scientific Progress and Financial Position - Vaxart is advancing its oral vaccine development, with significant milestones including rapid enrollment in a COVID-19 Phase 2b trial and positive results for a norovirus vaccine [10][12]. - The company is focused on extending its cash runway into 2026 through cost reductions while maintaining the ability to deliver multiple data readouts [10]. - Vaxart's proprietary delivery platform for oral vaccines positions it to develop innovative solutions for various health challenges [14].

Core Viewpoint - High-Trend International Group is implementing a reverse stock split to meet Nasdaq listing requirements, specifically to maintain a minimum bid price of $1.00 per share [2][3]. Group 1: Reverse Stock Split Details - The reverse stock split will occur at a ratio of 1-for-25, changing the par value of the Ordinary Shares from $0.0001 to $0.0025 [1][3]. - The effective date of the reverse stock split is set for August 7, 2025, with trading on a split-adjusted basis commencing on August 8, 2025 [3]. - The total number of outstanding Ordinary Shares will decrease from approximately 140 million to about 5.6 million shares [4]. Group 2: Impact on Shareholders - The reverse stock split will uniformly affect all holders of Ordinary Shares, without altering any shareholder's percentage ownership in the company [5]. - Shareholders holding shares in book-entry form or through intermediaries will not need to take any action, as the changes will be reflected in their accounts post-split [5].

Core Points - Vivid Seats Inc. announced a 1-for-20 reverse stock split of its Class A and Class B common stock, effective at 5:00 p.m. Eastern Time on August 5, 2025, with trading on a split-adjusted basis starting on August 6, 2025 [1][2] - The reverse stock split was approved by stockholders on July 21, 2025, and will combine every 20 shares of common stock into one share, with fractional shares being compensated in cash [2] - The reverse stock split will not affect stockholders' percentage ownership or voting power, except for fractional shares, and all outstanding warrants and equity-based awards will be proportionately adjusted [2] Company Information - Vivid Seats, founded in 2001, is a leading online ticket marketplace that connects fans with live events, artists, and teams, emphasizing the belief that everyone should "Experience It Live" [5] - The company offers a wide selection of events and tickets in North America and features an industry-leading rewards program where fans earn on every purchase [5] - Vivid Seats has been recognized by Newsweek as one of America's Best Companies for Customer Service in ticketing [5]

Core Viewpoint - Calidi Biotherapeutics, Inc. announced a reverse stock split at a ratio of 1-for-12 to optimize market dynamics and broaden investor appeal, effective August 5, 2025 [1][2]. Company Overview - Calidi Biotherapeutics is a clinical-stage biotechnology company focused on developing targeted therapies that deliver genetic medicines to disease sites, utilizing its proprietary Redtail platform [6][7]. - The Redtail platform is designed to create viral vectors that evade immune detection, allowing for effective delivery of virotherapy to tumor sites [6]. Reverse Stock Split Details - The reverse stock split will consolidate every twelve pre-split shares into one post-split share, with fractional shares rounded up to the nearest whole share at the participant level [3][4]. - The split was approved by stockholders on July 9, 2025, and by the Board of Directors on July 11, 2025 [2]. - The new CUSIP number for the common stock will be 320703 408 following the split [1]. Stockholder Information - Registered stockholders with book-entry shares will not need to take action to receive post-split shares, while those with shares in certificate form will receive instructions for exchanging their certificates [5].

Core Viewpoint - Velo3D, Inc. has announced a 1-for-15 reverse stock split of its common stock to prepare for a potential listing on a national securities exchange, with the split expected to take effect on July 28, 2025 [1][3]. Group 1: Reverse Stock Split Details - The reverse stock split will convert every 15 shares of common stock into one new share, reducing the outstanding shares from approximately 211,011,238 to about 14,067,416 [3]. - The reverse stock split was approved by Velo3D's stockholders on June 27, 2025, and the final ratio was determined by the board on July 18, 2025 [1][3]. - The CUSIP number for the common stock will change to 92259N 302, and the trading symbol will temporarily change to "VLDXD" for 20 business days [1][2]. Group 2: Impact on Shareholders - Fractional shares will not be issued; instead, stockholders entitled to a fractional share will receive one full share [3]. - The number of authorized shares will remain at 500,000,000, and the par value will stay at $0.00001 per share [2][3]. - Proportional adjustments will be made to the exercise prices of outstanding stock options and warrants, as well as to equity-based awards [3]. Group 3: Company Overview - Velo3D specializes in additive manufacturing technologies for mission-critical metal parts, enabling the production of complex designs previously deemed impossible [6][7]. - The company has developed a fully integrated solution that includes Flow print preparation software, the Sapphire family of printers, and the Assure quality control system, powered by its Intelligent Fusion manufacturing process [7]. - Velo3D has been recognized as one of Fast Company's Most Innovative Companies for 2024 and has partnered with notable companies such as SpaceX and Honeywell [7].